Avelumab versus standard second-line treatment chemotherapy in metastatic colorectal cancer (mCRC) patients with microsatellite instability (MSI): The SAMCO-PRODIGE 54 randomised phase II trial
ANNÉE
2022
AUTEURS
Taieb J, Bouche O, André T, Barbier E, Laurent-Puig P, Bez J, Toullec C, Borg C, Randrian V, Evesque L, Corbinais S, Buecher B, H. Perrier H, Di Fiore F, Gallois C, Lepage C, El Hajbi F, Tougeron D
CONGRÈS/REVUE
ESMO
LIEN PUBLICATIONS ASSOCIÉES